Acasti Pharma to Present CaPre Omega-3 Bridging Study

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
45
Acasti Pharma to Present CaPre Omega-3 Bridging Study Results at National Lipid Association Scientific Sessions

LAVAL, QUÉBEC--(Marketwired - April 12, 2017) - Acasti Pharma Inc. (NASDAQ:ACST)(TSX VENTURE:ACST) today announced that company researchers have been invited to present the CaPre ® (omega-3 phospholipid) bridging study results in a poster presentation at the National Lipid Association Scientific Sessions in Philadelphia, May 18-21, 2017. Acasti will present the results of its 'Phase 1, Single-Dose, Comparative Bioavailability Study of CaPre, a novel Omega-3 Derived from Krill Oil and Lovaza® under Fasting and Fed Conditions.'

"The selection of CaPre data for a poster presentation at this key medical meeting underscores the importance of providing the medical community with new information about therapy advancements in the treatment of hypertriglyceridemia," said Pierre Lemieux, Ph.D., Acasti's chief operating officer. "Data to be presented will highlight Acasti's commitment to providing hypertriglyceridemia patients and treating physicians with a well-absorbing omega-3 therapeutic that may also have a positive impact on the major lipids associated with cardiovascular disease risk."

Acasti has successfully completed two Phase 1 and two Phase 2 clinical trials with CaPre for the treatment of hypertriglyceridemia. The outcome of the recent End-of-Phase 2 Meeting with the U.S. Food and Drug Administration confirmed that the Phase 3 program is on track to start late 2017.

About CaPre (omega-3 phospholipid)

Acasti's prescription drug candidate, CaPre, is a highly purified omega-3 phospholipid concentrate derived from krill oil and is being developed to treat severe hypertriglyceridemia, a metabolic condition that contributes to increased risk of cardiovascular disease and pancreatitis. Its omega-3s, principally EPA and DHA, are either "free" or bound to phospholipids that help them to be better absorbed into the body. This allows for enhanced bioavailability and EPA and DHA blood levels compared to the "esterified" fish-oil omega-3 options such as LOVAZA.

About Acasti Pharma

Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the U.S. population. The corporation's strategy is to initially develop and commercialize CaPre for the three to four million patients in the U.S. with severe hypertriglyceridemia. Since its founding in 2008, Acasti Pharma has focused on addressing a critical market need for an effective, safe and well-absorbing omega-3 therapeutic that can make a positive impact on the major blood lipids associated with cardiovascular disease risk. For more information, visit www.acastipharma.com .

Forward Looking Statements

Statements in this press release that are not statements of historical or current fact constitute "forward looking statements" and "forward-looking information" (collectively, "forward-looking statements") within the meaning of the U.S. securities laws and Canadian securities laws, including, without limitation, statements with respect to the proposed initiation of the Phase 3 development program for CaPre and the timing of such development program. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Acasti to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Certain important assumptions by Acasti in making forward-looking statements include, but are not limited to, Acasti's ability to obtain additional capital and financing as needed on favorable terms, Acasti's ability to take advantage of business opportunities in the pharmaceutical industry and the receipt of strategic partner support, and Acasti's estimate of the timeline and costs for its development programs not being affected by unforeseen events or circumstances. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.

The forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement and the "Cautionary Note Regarding Forward-Looking Information" section contained in Acasti's latest Annual Information Form, which also forms part of Acasti's latest annual report on Form 20-F, and which is available on SEDAR at www.sedar.com , on EDGAR at www.sec.gov/edgar.shtml and on the investor section of Acasti's website at acastipharma.com (the "AIF"). All forward-looking statements in this press release are made as of the date of this press release. Acasti does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in Acasti's public securities filings with the Securities and Exchange Commission and the Canadian securities regulators. Additional information about these assumptions and risks and uncertainties is contained in the AIF under "Risk Factors."

Neither NASDAQ, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Acasti Pharma Inc.

Acasti Contact: Jan D'Alvise Chief Executive Officer 450-686-4555 info@acastipharma.com www.acastipharma.com Media & Investor Contact: Jessica Dyas Canale Communications 619-849-5385 jessica@canalecomm.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Roland DG's Brand Refresh Earns Three B2B Awards in 2026

Updated Category News Views 98

Three trophies for a printer-maker’s marketing overhaul will not move mountains by themselves, but they do tell us Roland DG has stopped treating its brand like an afterthought. The company’s global Make Your Mark refresh picked up two Silver awards and one Bronze at the 2026 Drum B2B Awards in Miami. For a business selling industrial-grade tools into crowded,...

Continue Reading
Layne’s Jacksonville Debut Tests East Texas Expansion

Updated Category News Views 57

Jacksonville is not some flashy coastal launch, and that is precisely why this Layne’s Chicken Fingers opening matters. A new chicken tender shop at 1217 S. Jackson St. will not move public markets, because this is a franchise-growth story rather than a ticker story. But it does offer a clean look at whether Layne’s can turn its Texas roots into a durable multi-market...

Continue Reading
Hyster-Yale's $125 Million Convertible Debt Shuffle

Updated Category News Views 142

Forklifts do not make headlines often, but debt terms sure can. Hyster-Yale has proposed a $125 million private offering of convertible senior notes due November 15, 2031, with buyers able to take another $18.75 million if the initial purchasers exercise their option. For NYSE:HY holders, this is not a victory lap or a distress flare by itself. It is a refinancing...

Continue Reading
LevelTen Takes Its Clean-Power Market Model to India

Updated Category News Views 77

India's power market is not a tidy spreadsheet, thankfully. It is a vast, fast-growing grid where data centres, factories and climate exposure are all colliding with a generation mix still dominated by coal. That is why LevelTen Energy's move into Asia-Pacific deserves more than the usual clean-tech applause line. Beginning with a 500 MW clean-energy request for proposals...

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 92

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
Polsen Flex Deal Puts Pre-Tax Funds Behind Wearables

Updated Category News Views 141

A pile of soon-to-expire FSA cash is a peculiar sales catalyst, but Polsen Health has found one. The Amsterdam-based preventative-health wearable company is partnering with Flex to let customers pay for every Polsen watch and strap using eligible HSA or FSA funds at checkout. No reimbursement chase, no claim forms, and buyers can split the cost with another card. For a...

Continue Reading
MetaOptics Tests a Real Path Into Secure Imaging Markets

Updated Category News Views 84

Fingerprint scanners have never impressed me much; fooling one is exactly the sort of nuisance that keeps security buyers spending. MetaOptics’ new collaboration with Hong Kong’s ASTRI goes after that uncomfortable problem with a compact nano-optics imaging system built for biometric security and smart sensing. It is a sensible target. It is also, at this stage, a...

Continue Reading
Seeking Alpha Premium Review: Data Meets Human Judgment

Updated Category News Views 159

A spreadsheet can spot a cracked windshield, but it cannot tell you where the truck is headed. That is the useful, slightly irritating truth behind Seeking Alpha Premium’s 2026 pitch: it puts an enormous amount of stock-research machinery in one place, yet the investor still has to do the driving. Software Experts has highlighted the service in its review of...

Continue Reading
Teachers in Space Takes Its Classroom Model Orbital

Updated Category News Views 114

Two teachers strapped into a research flight may sound like a glossy space-age photo op, but the useful part of this plan sits back in the classroom with the students staring at the data. Teachers in Space wants to send two educators aboard a Virgin Galactic research flight expected in 2027, and it is raising $2 million to fund the broader educational program and mission....

Continue Reading
24X Options Filing Puts Earnings Bets Before the SEC

Updated Category News Views 121

An earnings release already turns the market into a bar fight; 24X wants to put part of that fight inside a regulated binary-options contract. The Stamford-based exchange has filed a proposed rule change with the SEC for 24X Options, a facility that would offer a conventional options market alongside contracts tied to company performance targets. It is an interesting...

Continue Reading

Top 5 Most Recently Viewed Articles

Sought-After Bourbons to Shine at Art of Bourbon Auction

Updated Category News Views 227

Discover Rare Bourbons at the Upcoming Art of Bourbon Auction On September 12, the Speed Art Museum will host a remarkable auction featuring some of the rarest and most coveted bourbons in the world. This event is sure to attract bourbon lovers and collectors, offering a unique chance to bid on exclusive whiskey selections. Event Details and Ticket Information The live...

Continue Reading
Forbright Bank Celebrated as Leader in Eco-Friendly Banking

Updated Category News Views 258

Forbright Bank Recognized for Environmental Excellence Forbright Bank has proudly received the prestigious title of Best Eco-Friendly Bank in America by Bankrate. This accolade, part of Bankrate’s Best Products in Personal Finance Awards, highlights Forbright Bank's unwavering dedication to sustainability and responsible lending practices. Notably, this award is making...

Continue Reading
Massimo Group Introduces Exciting New UTV Models for Enthusiasts

Updated Category News Views 183

Massimo Group Expands UTV Lineup with the Buck 450 and T-Boss 900L Crew Massimo Group (NASDAQ: MAMO), a prominent manufacturer and distributor of powersports vehicles, is rolling out two exciting additions to its UTV lineup: the Buck 450 4WD UTV and the T-Boss 900L Crew UTV. These new models aim to enhance the company's offerings and strengthen collaborations with retail...

Continue Reading
LightBox CRE Index Shows Remarkable Growth Amid Policy Changes

Updated Category News Views 186

The Rise of the LightBox CRE Activity Index Successful trends in the commercial real estate (CRE) market are significantly highlighted by the recent surge in the LightBox CRE Activity Index. The index recorded a remarkable increase to 96.1 in February, marking an impressive rise from 80.7 in January and 75.8 a year ago. This surge points to a 19% month-over-month and 27%...

Continue Reading
D/Quarters Expands to Meet Rising Demand at Dubai Science Park

Updated Category News Views 180

D/Quarters Expands to Meet Rising Demand at Dubai Science Park D/Quarters, a leading provider of high-quality co-working spaces from TECOM Group PJSC, is expanding its footprint in Dubai Science Park, doubling the size of its offices. This decision arises from the increasing demand for versatile workspaces amid the city's dynamic business landscape. Growing Demand for...

Continue Reading